Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Merrimack Pharmaceuticals Inc (MACK)
Merrimack Pharmaceuticals Inc (MACK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Merrimack Pharmaceuticals Inc ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 USA

www.merrimackpharma.com P: 617-720-8606

Description:

Merrimack Pharmaceuticals, Inc., is a biopharmaceutical company focused on the discovery, development and preparation to commercialize innovative medicines paired with companion diagnostics for the treatment of serious diseases, with a special focus on cancer. Merrimack Pharmaceuticals, Inc. is headquartered in Cambridge, Massachusetts.

Key Statistics

Overview:

Market Capitalization, $K 183,738
Enterprise Value, $K 164,298
Shares Outstanding, K 14,321
Annual Sales, $ 0 K
Annual Net Income, $ -1,540 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -280 K
EBIT, $ -2,160 K
EBITDA, $ -2,160 K
60-Month Beta 1.58
% of Insider Shareholders 28.87%
% of Institutional Shareholders 55.90%
Float, K 10,187
% Float 71.13%
Short Volume Ratio 0.34

Growth:

1-Year Return 6.59%
3-Year Return 74.31%
5-Year Return 209.31%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 98.06%
5-Year Dividend Growth -100.00%

Per-Share Information:

Most Recent Earnings -0.02 on 11/02/23
Next Earnings Date N/A
Earnings Per Share ttm -0.10
EPS Growth vs. Prev Qtr 33.33%
EPS Growth vs. Prev Year 33.33%
Annual Dividend Yield 0.00%
Next Ex-Dividends Date 05/30/17
Dividend Payable Date 05/26/17
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 09/06/17

MACK Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -7.52%
Return-on-Assets % -7.33%
Profit Margin % 0.00%
Net Margin % N/A
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 9.82
Book Value/Share 1.31
Interest Coverage -0.11
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar